Result: Leukoreductive response to the combination of sorafenib and chemotherapy in hyperleukocytosis of FLT3-ITD mutated pediatric AML

*Title*:

Leukoreductive response to the combination of sorafenib and chemotherapy in hyperleukocytosis of FLT3-ITD mutated pediatric AML / Franziska Schmidt, Miriam Erlacher, Charlotte Niemeyer, Dirk Reinhardt, Jan-Henning Klusmann

*Author/editor-in-chief*:

Schmidt, Franziska (Verfasser); Erlacher, Miriam (Verfasser) ; Niemeyer, Charlotte (Verfasser) ; Reinhardt, Dirk (Verfasser); Klusmann, Jan-Henning (Verfasser)

*Published in*:

Frontiers in pediatrics. - Lausanne : Frontiers Research Foundation, 09.11.2022. - 10.3389/fped.2022.1046586. - ISSN 2296-2360. - Jahrgang 10, Artikel 1046586

*Publication*:

Lausanne : Frontiers Research Foundation, 09.11.2022

*Distribution*:

Frankfurt am Main : Universitätsbibliothek Johann Christian Senckenberg

*Physical description scale*:

1 Online-Ressource (8 Seiten)

*Format*:

*eBook*

*Language*:

*eng*

*DOI*:

10.3389/fped.2022.1046586

*oa_rights*:

Open Access
CC BY 4.0

*Result*: Leukoreductive response to the combination of sorafenib and chemotherapy in hyperleukocytosis of FLT3-ITD mutated pediatric AML

*Additional information*

*Additional functions*

Result: Leukoreductive response to the combination of sorafenib and chemotherapy in hyperleukocytosis of FLT3-ITD mutated pediatric AML

Additional information

Additional functions